The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.
Soon Tae LeeHan Sang LeeWoo-Jin LeeHan-A ChaSeon Hui KimSeo-Yi ShinKon ChuSang Kun LeePublished in: Annals of clinical and translational neurology (2022)
IVIG improved neurological functional outcomes, and the improvement was evident by day 8. Adverse effects were tolerable. These data provide the prospective evidence regarding the efficacy of IVIG in improving the functional outcomes of autoimmune encephalitis.